Plasma Protein Kallikrein-14 Strongly Predicts Pronounced Chromogranin A (CgA) Response in Small Intestinal Neuroendocrine Tumor (NET) Patients after Somatostatin Analog (SSA) Treatment: The Nordic EXPLAIN Biomarker StudyShow others and affiliations
2018 (English)In: Neuroendocrinology, ISSN 0028-3835, E-ISSN 1423-0194, Vol. 106, no Supplement: 1, p. 155-155Article in journal, Meeting abstract (Other academic) Published
Place, publisher, year, edition, pages
2018. Vol. 106, no Supplement: 1, p. 155-155
Keywords [en]
plasma protein biomarker
National Category
Endocrinology and Diabetes
Identifiers
URN: urn:nbn:se:uu:diva-355841DOI: 10.1159/000487699ISI: 000427285300153OAI: oai:DiVA.org:uu-355841DiVA, id: diva2:1232915
Conference
15th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, MAR 07-09, 2018, Barcelona, SPAIN
Note
Meeting Abstract: F08
2018-07-132018-07-132018-07-13Bibliographically approved